Mislabeled fentanyl patches recalled

Alvogen, a pharmaceutical company based in New Jersey, is recalling two lots of its transdermal fentanyl patches due to faulty product labeling.

The affected lots of Fentanyl Transdermal System 12 mcg/h transdermal patches were distributed to pharmacies.

Alvogen said a small number of cartons labeled as containing 12 mcg/h patches actually contain 50 mcg/h patches, which are individually labeled as having the 50 mcg/h dose.

3M Drug Delivery Systems manufacturers the product, which helps manage pain in opioid-tolerant patients.

More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant 'illness' spur FDA safety review
5 supply chain technologies to watch

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers